Purpose: To synthesize and compare available evidence considering the effectiveness of carbon-ion, proton and photon radiotherapy for head and neck cancer.
Methods: A systematic review and meta-analyses were performed to retrieve evidence on tumor control, survival and late treatment toxicity for carbon-ion, proton and the best available photon radiotherapy.
Results: In total 86 observational studies (74 photon, 5 carbon-ion and 7 proton) and eight comparative in-silico studies were included. For mucosal malignant melanomas, 5-year survival was significantly higher after carbon-ion therapy compared to conventional photon therapy (44% versus 25%; P-value 0.007). Also, 5-year local control after proton therapy was significantly higher for paranasal and sinonasal cancer compared to intensity modulated photon therapy (88% versus 66%; P-value 0.035). No other statistically significant differences were observed. Although poorly reported, toxicity tended to be less frequent in carbon-ion and proton studies compared to photons.
In-silico studies showed a lower dose to the organs at risk, independently of the tumor site.
Conclusions: For carbon-ion therapy, the increased survival in mucosal malignant melanomas might suggest an advantage in treating relatively radio-resistant tumors. Except for paranasal and sinonasal cancer, survival and tumor control for proton therapy were generally similar to the best available photon radiotherapy. In agreement with included in-silico studies, limited available clinical data indicates that toxicity tends to be lower for proton compared to photon radiotherapy.
Since the overall quantity and quality of data regarding carbon-ion and proton therapy is poor, we recommend the construction of an international particle therapy register to facilitate definitive comparisons. (C) 2010 Elsevier Ltd. All rights reserved.
- Head and neck cancer
- Systematic review
- ADENOID CYSTIC CARCINOMA
- INTENSITY-MODULATED RADIOTHERAPY
- SQUAMOUS-CELL CARCINOMA
- ADVANCED NASOPHARYNGEAL CARCINOMA
- ADVANCED SINONASAL MALIGNANCIES
- ADJUVANT RADIATION-THERAPY
- CURRENT CLINICAL-EVIDENCE
- PRIMARY MUCOSAL MELANOMA
- PARANASAL SINUSES